Tarsus Share Price

Tarsus Share Price

NASDAQ: TARS | Mid Cap | Healthcare
$76.61
-$1.54 (-1.97%) Last updated on 19 Nov, 2026 | 01:25 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Tarsus Stock Performance

Open
$78.27
Prev. Close
$78.15
Circuit Range
N/A
Day Range
$76.44 - $79.53
Year Range
$54.18 - $91.44
Volume
22,852
Average Traded
$77.90

Tarsus Share Price Today

As of 19 November 2026, Tarsus Pharmaceuticals, Inc.'s share price is $76.61. The stock opened at $78.27, compared to its previous close of $78.15. During today's trading session, Tarsus Pharmaceuticals, Inc.'s share price traded between $76.44 and $79.53, with an average price of $77.98. Over the past 52 weeks, the stock has recorded a high of $91.44 and a low of $54.18. In terms of performance, Tarsus Pharmaceuticals, Inc.'s share price has risen by 29.10% over the last six months and is down 4.49% on a year-on-year basis.

Tarsus Share Price Chart

Line chart of the Tarsus price trend over the selected period. The price fell overall, ranging from 76.44 to 79.57, ending at 76.61.
$76.44$79.53
L
Show Current Price
H

Tarsus Stock Fundamentals & Key Indicators

Market Cap
$3.20B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-14.25
Revenue (TTM)
$451.36B
Return On Equity (TTM)
-675.49%
Profit Margin
-14.67%
Debt to Equity
0.70
Quarterly Earnings Growth YoY
-8080.29%

Tarsus Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$151.67$162.05$173.91$194.57
Net Profit-$8.17-$7.65-$18.55-$668.33
Net Profit Margin-5.39%-4.72%-10.67%-343.49%
Income ChangeN/A6.36%-142.48%-3502.86%

Tarsus Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$25.82$17.45$182.95$451.36
Net Profit-$62.09-$135.82-$115.37-$66.22
Net Profit Margin-240.47%-778.34%-63.06%-14.67%
Income ChangeN/A-118.75%15.06%42.60%

Tarsus Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets39.3820.299.362.49
Current Assets522.78356.71256.13225.38
Total Assets562.16376.99265.49227.86
Non Current Liabilities83.0471.8531.5719.53
Current Liabilities135.780.6136.9415.43
Total Liabilities218.73152.4668.534.96
Shareholders' Equity343.43224.53196.99192.9

Tarsus Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-12.45-83.03-117.49-49.03
Investing-42.12-199.2140.6-144.63
Financing143.39154.66130.1893.99

About Tarsus

Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis. TP-04 for the potential treatment of ocular rosacea and TP-05 for potential Lyme disease prophylaxis and community malaria reduction.

Tarsus Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$75.50
$76.52
+2.35%
Oct 2026
$79.03
$74.76
-4.66%
Sep 2026
$74.11
$78.42
+8.99%
Aug 2026
$60.15
$71.95
+22.02%
Jul 2026
$65.04
$58.97
-6.18%
Jun 2026
$59.26
$62.85
+5.92%
May 2026
$62.60
$59.34
-6.84%
Apr 2026
$70.71
$63.70
-9.09%
Mar 2026
$74.11
$70.07
-7.20%
Feb 2026
$65.19
$75.51
+16.98%
Jan 2026
$81.56
$64.55
-21.29%
Dec 2025
$80.00
$82.02
+2.24%

Tarsus Share Price FAQs